Dynex Capital Inc. (DX) Jumps 6% on January 26

Equities Staff |

Dynex Capital Inc. (DX) was among the biggest gainers on the Russell 2000 for Tuesday January 26 as the stock popped 6% to $5.83, representing a gain of $0.33 per share. Some 256,647 shares traded hands on 1,427 trades, compared with an average daily volume of 350,160 shares out of a total float of 49.17 million. The stock opened at $5.51 and traded with an intraday range of $5.84 to $5.50.

After today's gains, Dynex Capital Inc. reached a market cap of $286.65 million. Dynex Capital Inc. has had a trading range between $8.50 and $5.22 over the last year, and it had a 50-day SMA of $6.31 and a 200-day SMA of $6.62.

Dynex Capital Inc is a real estate investment trust, which invests in mortgage loans and securities on a leveraged basis.

Dynex Capital Inc. is based out of Glen Allen, VA and has some 17 employees. Its CEO is Byron L. Boston.

For a complete fundamental analysis analysis of Dynex Capital Inc., check out Equities.com’s Stock Valuation Analysis report for DX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…